Solventum (NYSE: SOLV), spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%. With solid revenue growth in this quarter, the company also announced yesterday evening that it is slightly bumping up its outlook for full-year organic sales. Investors reacted by ending SOLV […]
Solventum
Solventum inks 3D dental printing partnership with SprintRay
Solventum (NYSE:SOLV) announced a strategic partnership with SprintRay to deliver disruptive 3D printing for dental technologies. The company says the partnership aims to meet the needs of dentists with in-office chairside 3D-printed crowns, inlays, onlays and more. This R&D and commercialization focuses on developing and bringing to market permanent, same-day restorations. Solventum Dental Solutions connects […]
Solventum offers new details on layoffs and plans for growth
Solventum said today that it cut 800 employees in a previously reported restructuring after spinning out from 3M last year. The layoffs and other restructuring expenses cost $120 million to execute but are estimated to save the company $120 million per year going forward. In the first year, the savings from the restructuring “offsets the […]
Solventum hires chief strategy officer out of Zimmer Biomet
Solventum (NYSE:SOLV) has appointed former Zimmer Biomet executive Rachel Ellingson as chief strategy and corporate development officer. Ellingson made the announcement on LinkedIn. She joins the company after a seven-year stint at Zimmer Biomet, where she was most recently chief administrative officer. Before that, she was chief strategy officer for six years. She has held numerous […]
Solventum beats The Street in Q4 — but stock is down
Solventum (NYSE:SOLV) stock is down today even though fourth-quarter results came in ahead of the consensus forecast on Wall Street. Shares of SOLV were down more than 4% to $79.17 apiece by afternoon trading today. Yesterday evening, the St. Paul, Minnesota–based healthcare spinoff from 3M reported profits of $30 million. That equals 17¢ per share […]
Solventum to sell Purification and Filtration business for $4.1B
Thermo Fisher Scientific today announced plans to acquire Solventum‘s Purification and Filtration business for $4.1 billion in cash. Solventum (NYSE: SOLV) — which spun out of 3M last year — saw its stock rise more than 8% to $82.76 per share in morning trading on the news. Thermo Fisher (NYSE: TMO) shares were mostly unchanged […]
Solventum announces layoffs
Solventum (NYSE: SOLV), previously 3M’s Health Care business, is engaging in a round of layoffs. The Star Tribune of Minnesota broke the news today, citing a video message that CEO Bryan Hanson sent to employees at the Twin-Cities-headquartered company. According to the newspaper, Hanson said: “We may be eliminating these positions to refocus our investments, […]
Solventum launches first 3D-printed dental aligner attachments
Solventum (NYSE:SOLV) announced today that it launched its 3M Clarity precision grip attachments for the 3M Clarity aligners. St. Paul Minnesota-based Solventum — the 3M Health Care spinoff — said the attachments are designed to solve one of the biggest challenges with aligner treatment: creating durable, accurately shaped, stain-resistant attachments. Solventum said the attachments could […]
Solventum raises guidance again after beating The Street in Q3
Solventum (NYSE:SOLV) reported third-quarter results that came in ahead of the consensus forecast on Wall Street. However, shares of SOLV were down 3% to $72.63 apiece in mid-day trading. In its second quarterly earnings report as an independent company, the Maplewood, Minnesota–based 3M Health Care spinoff reported profits of $122 million. That equals 70¢ per […]
Solventum to spend $209M on new Minnesota HQ
Solventum, formerly 3M’s healthcare business, will spend $209 million on a new headquarters in Minnesota, state economic development officials announced today. The Minnesota Department of Employment and Economic Development said the state will provide nearly $13 million in business development funding to support the project, which will retain an estimated 2,000 jobs in the North […]
Solventum picks a surgeon as its new chief medical officer
Solventum (NYSE:SOLV) announced today that it named Dr. Ryan Egeland as its chief medical officer (CMO). St. Paul, Minnesota-based Solventum — the 3M Healthcare spinoff — made Egeland responsible for leading its global medical and clinical affairs team. In his role as CMO, Egeland aims to foster industry collaboration and identify innovation and market expansion […]
